BRIEF-Response Biomedical enters into contracts for going personal

Reaction Biomedical Corp: * Says offer for cash factor to consider of $1.12 per reaction
share * Gotten in into a definitive arrangement agreement with
1077801 B.C. Ltd, a business owned by Orbimed Asia Partners

* Says money consideration price represents a 51% premium to
closing cost of response shares

* Enters into conclusive contracts for going private
transaction and private placement

Source text for Eikon: More company protection:

( Bengaluru Newsroom).

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *